3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
8
Completed
8
Unknown
4
Terminated
4
Active not recruiting
2
Not yet recruiting
1
Sponsor Class
OTHER
4
Study Type
Observational
2
Interventional
2
Sponsor
Cancer Type
Gynecologic
3
Head & Neck
1
Endocrine
1
Conditions
Breast Neoplasms
1476
Neoplasms
999
Colorectal Neoplasms
830
Carcinoma, Non-Small-Cell Lung
724
Carcinoma, Hepatocellular
683
Stomach Neoplasms
647
Lung Neoplasms
584
Prostatic Neoplasms
543
Pancreatic Neoplasms
456
Rectal Neoplasms
338
Uterine Cervical Neoplasms
303
Colonic Neoplasms
295
Neoplasm Metastasis
292
Ovarian Neoplasms
285
Esophageal Neoplasms
279
Recurrence
278
Leukemia, Myeloid, Acute
253
Head and Neck Neoplasms
241
Multiple Myeloma
232
Brain Neoplasms
204
Polycystic Ovary Syndrome
200
Nasopharyngeal Carcinoma
198
Melanoma
198
Precursor Cell Lymphoblastic Leukemia-Lymphoma
195
Urinary Bladder Neoplasms
193
Lymphoma
178
Liver Neoplasms
178
Endometrial Neoplasms
159
Motor Activity
147
Lymphoma, Large B-Cell, Diffuse
141
Interventions
niraparib
1
Diffusion
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
Unknown
×
OTHER
×
Endocrine Gland Neoplasms
×
Clear all
NCT03973450
2021-09-08
EpidemioPIT
Neuromed IRCCS
Unknown
400 enrolled
NCT04556071
2020-11-10
AVANIRA3
Jiangsu Cancer Institute & Hospital
Phase 2
Unknown
32 enrolled
NCT02836275
2020-04-14
IOTA-MRI
KU Leuven
Phase NA
Unknown
250 enrolled
NCT02847832
2020-04-14
IOTA7
KU Leuven
Unknown
1,700 enrolled